hearingloss-study.info hearingloss-study.info

hearingloss-study.info

Hearing loss treatment: Clinical trial for novel drug candidate

Novel drug candidate for idiopathic sudden hearing loss: Clinical trial on the efficacy of AM-111 for the treatment of idiopathic sudden sensorineural hearing loss. Information for professionals.

http://www.hearingloss-study.info/

WEBSITE DETAILS
SEO
PAGES
SIMILAR SITES

TRAFFIC RANK FOR HEARINGLOSS-STUDY.INFO

TODAY'S RATING

>1,000,000

TRAFFIC RANK - AVERAGE PER MONTH

BEST MONTH

July

AVERAGE PER DAY Of THE WEEK

HIGHEST TRAFFIC ON

Saturday

TRAFFIC BY CITY

CUSTOMER REVIEWS

Average Rating: 3.3 out of 5 with 3 reviews
5 star
1
4 star
1
3 star
0
2 star
0
1 star
1

Hey there! Start your review of hearingloss-study.info

AVERAGE USER RATING

Write a Review

WEBSITE PREVIEW

Desktop Preview Tablet Preview Mobile Preview

LOAD TIME

1.4 seconds

FAVICON PREVIEW

  • hearingloss-study.info

    16x16

  • hearingloss-study.info

    32x32

CONTACTS AT HEARINGLOSS-STUDY.INFO

Login

TO VIEW CONTACTS

Remove Contacts

FOR PRIVACY ISSUES

CONTENT

SCORE

6.2

PAGE TITLE
Hearing loss treatment: Clinical trial for novel drug candidate | hearingloss-study.info Reviews
<META>
DESCRIPTION
Novel drug candidate for idiopathic sudden hearing loss: Clinical trial on the efficacy of AM-111 for the treatment of idiopathic sudden sensorineural hearing loss. Information for professionals.
<META>
KEYWORDS
1 sudden deafness trial
2 div uk panel'} data uk grid margin
3 hearing loss study
4 for patients
5 dozvíte se více
6 pro pacienty
7 hörsturz studie
8 mehr erfahren
9 für medizinisches fachpersonal
10 für patienten
CONTENT
Page content here
KEYWORDS ON
PAGE
sudden deafness trial,div uk panel'} data uk grid margin,hearing loss study,for patients,dozvíte se více,pro pacienty,hörsturz studie,mehr erfahren,für medizinisches fachpersonal,für patienten,halláscsökkenés vizsgálat,tudjon meg többet,betegeknek,imprint
SERVER
Apache
POWERED BY
PHP/5.6.19
CONTENT-TYPE
utf-8
GOOGLE PREVIEW

Hearing loss treatment: Clinical trial for novel drug candidate | hearingloss-study.info Reviews

https://hearingloss-study.info

Novel drug candidate for idiopathic sudden hearing loss: Clinical trial on the efficacy of AM-111 for the treatment of idiopathic sudden sensorineural hearing loss. Information for professionals.

INTERNAL PAGES

hearingloss-study.info hearingloss-study.info
1

Hearing loss treatment: Clinical trial for novel drug candidate

http://www.hearingloss-study.info/hu/hirtelen-fellepo-hallasvesztes-vizsgalat

To date, no pharmaceutical treatment for acute sensorineural hearing loss (ASNHL) with clear evidence-based efficacy is available. A phase II trial with intratympanic AM-111 administration provided the proof of concept for AM-111’s ability to protect hearing in case of sudden sensorineural hearing loss. The drug was also well tolerated (Suckfüll et al., 2014). For Health Care Professionals. Изпитване при пациенти със загуба на слуха. Studie u pacientů se ztrátou sluchu. URČENO PRO ZDRAVOTNICKÉ ODBORNÍKY.

2

Hearing loss treatment: Clinical trial for novel drug candidate

http://www.hearingloss-study.info/pl/badanie-dotyczace-naglej-utraty-sluchu-personelu-medycznego

To date, no pharmaceutical treatment for acute sensorineural hearing loss (ASNHL) with clear evidence-based efficacy is available. A phase II trial with intratympanic AM-111 administration provided the proof of concept for AM-111’s ability to protect hearing in case of sudden sensorineural hearing loss. The drug was also well tolerated (Suckfüll et al., 2014). For Health Care Professionals. Изпитване при пациенти със загуба на слуха. Studie u pacientů se ztrátou sluchu. URČENO PRO ZDRAVOTNICKÉ ODBORNÍKY.

3

Hearing loss treatment: Clinical trial for novel drug candidate

http://www.hearingloss-study.info/ru/domashnyaya-stranitsa

To date, no pharmaceutical treatment for acute sensorineural hearing loss (ASNHL) with clear evidence-based efficacy is available. A phase II trial with intratympanic AM-111 administration provided the proof of concept for AM-111’s ability to protect hearing in case of sudden sensorineural hearing loss. The drug was also well tolerated (Suckfüll et al., 2014). For Health Care Professionals. Изпитване при пациенти със загуба на слуха. Studie u pacientů se ztrátou sluchu. URČENO PRO ZDRAVOTNICKÉ ODBORNÍKY.

4

Hearing loss treatment: Clinical trial for novel drug candidate

http://www.hearingloss-study.info/pl/strona-startowa

To date, no pharmaceutical treatment for acute sensorineural hearing loss (ASNHL) with clear evidence-based efficacy is available. A phase II trial with intratympanic AM-111 administration provided the proof of concept for AM-111’s ability to protect hearing in case of sudden sensorineural hearing loss. The drug was also well tolerated (Suckfüll et al., 2014). For Health Care Professionals. Изпитване при пациенти със загуба на слуха. Studie u pacientů se ztrátou sluchu. URČENO PRO ZDRAVOTNICKÉ ODBORNÍKY.

5

Hearing loss treatment: Clinical trial for novel drug candidate

http://www.hearingloss-study.info/hu

To date, no pharmaceutical treatment for acute sensorineural hearing loss (ASNHL) with clear evidence-based efficacy is available. A phase II trial with intratympanic AM-111 administration provided the proof of concept for AM-111’s ability to protect hearing in case of sudden sensorineural hearing loss. The drug was also well tolerated (Suckfüll et al., 2014). For Health Care Professionals. Изпитване при пациенти със загуба на слуха. Studie u pacientů se ztrátou sluchu. URČENO PRO ZDRAVOTNICKÉ ODBORNÍKY.

UPGRADE TO PREMIUM TO VIEW 13 MORE

TOTAL PAGES IN THIS WEBSITE

18

LINKS TO THIS WEBSITE

aurismedical.com aurismedical.com

AM-111 - Auris Medical : development of novel pharmaceutical therapies to prevent or treat severe inner ear disorders like tinnitus and hearing loss

http://www.aurismedical.com/product-candidates/am-111

AM-111 for the treatment of acute inner ear hearing loss. Auris Medical is developing AM-111 for the treatment of acute inner ear (sensorineural) hearing loss (ASNHL). AM-111 contains the synthetic peptide D-JNKI-1 ( D. Stereoisomer of c- J. AM-111 received orphan drug designation from both EMA and FDA for the treatment of ASNHL. AM-111 has the potential to become the first approved pharmaceutical treatment for ASNHL. Sorineural Hearing Loss T. Reatment; North America and South Korea, initiated in Q2/201...

UPGRADE TO PREMIUM TO VIEW 0 MORE

TOTAL LINKS TO THIS WEBSITE

1

OTHER SITES

hearingloss-mi.org hearingloss-mi.org

Home - Hearing Loss Association of America - Michigan State Association

Learn more about Hearing Technology Resource Specialists (HTRS). Hearing Loss Association of America - Michigan State Association. Michigan's Voice for People with Hearing Loss. Americans With Disabilities Act. About Chapters in Michigan. Hearing Technology Resource Specialists (HTRS) Program. Resource Documents & Blog Posts. Over-the-Counter Hearing Aid Act of 2017. Bringing Affordable and Accessible. Hearing Health Care Closer to Reality. More About OTC Bill Here. April 21,2018, 10am-3:30pm. Click on t...

hearingloss-nashville.org hearingloss-nashville.org

About

Hearing Loss Association of America. Made with HTML Egg Pro. We are a friendly group of people with mild to profound hearing loss who meet once a month for fellowship and to share information. We would love to meet you! Spouses, family members, and friends are welcome too! 1003 Hickory Hill Lane. Hermitage, TN 37076-1906. We just learned that one of the Past Presidents of our HLAA Nashville Chapter, Kent Bessee, has recently passed away. He was 77 years old. Author and Passion Mentor Karen Putz.

hearingloss-nj.org hearingloss-nj.org

Hearing Loss Association of New Jersey - Home Page

To serve as an extension of the Hearing Loss Association of America organization in creating awareness of hearing loss issues within the state of New Jersey. To develop a statewide network to help with outreach, advocacy, legislative and equal access issues that affect people with hearing loss. To network cooperatively with other organizations within the state which are concerned with hearing loss. Marvin H. Schaab.

hearingloss-nyc.org hearingloss-nyc.org

hearing loss | Hearing Loss Association of New York City

Hearing Loss Association of New York City. Degree of Hearing Loss. High Frequency Hearing Loss. What is Sensorineural Hearing Loss. Degree of Hearing Loss. High Frequency Hearing Loss. What is Sensorineural Hearing Loss. May 23, 2015. Treat hearing loss early experts say – Albuquerque Journal. Hearing Loss Causes [Reverse Tinnitus Fast].

hearingloss-spokane.org hearingloss-spokane.org

Home Page

Hearing Loss Association of America, Spokane Chapter. The Spokane Chapter of the Hearing Loss Association of America seeks to open the world of communication to people with hearing loss by providing information, education, support and advocacy. We meet monthly from Sept. to June on the second Saturday at 9:30 am the Hearing Loss Center, across from the Arena at Boone and Howard. 1206 N. Howard, Spokane, WA 99201. PO Box 30818, Spokane WA 99223-3013.

hearingloss-study.info hearingloss-study.info

Hearing loss treatment: Clinical trial for novel drug candidate

To date, no pharmaceutical treatment for acute sensorineural hearing loss (ASNHL) with clear evidence-based efficacy is available. A phase II trial with intratympanic AM-111 administration provided the proof of concept for AM-111’s ability to protect hearing in case of sudden sensorineural hearing loss. The drug was also well tolerated (Suckfüll et al., 2014). For Health Care Professionals. Studie u pacientů se ztrátou sluchu. URČENO PRO ZDRAVOTNICKÉ ODBORNÍKY. Badanie dotyczące utraty słuchu. Obecnie pr...

hearingloss-sv.org hearingloss-sv.org

Home

50 million people in the U.S. have a hearing loss? 30 of every one thousand school age children have a hearing loss? By age 65, one out of three people has a hearing loss? 78% of people with hearing loss experience their loss in adulthood? 76% of people who could benefit from hearing aids are not using them? People with hearing loss wait for an average of seven years before seeking help? Isolation, withdrawal and depression are the most common reactions to hearing loss? You Need To Know. How to get help.

hearingloss-swohio.org hearingloss-swohio.org

HLAA Southwest Ohio Chapter – Self-Help for the Hard of Hearing

HLAA Southwest Ohio Chapter. Self-Help for the Hard of Hearing. Welcome – You Are Not Alone. March 19, 2010. The Hearing Loss Association of America (HLAA) is the nation’s leading organization representing people with hearing loss. According to the National Center for Health Statistics 36 million (17%) American adults have some degree of hearing loss making it a public health issue…. Read more →. Kentucky Commission on the Deaf and Hard of Hearing. March 4, 2013. Read more →. January 20, 2013. Here is a ...

hearingloss-treatment.info hearingloss-treatment.info

hearingloss-treatment.info

The domain "hearingloss-treatment.info" is parked with 123ehost.com.

hearingloss-treatments.info hearingloss-treatments.info

hearingloss-treatments.info

The domain "hearingloss-treatments.info" is parked with 123ehost.com.

hearingloss-wa.org hearingloss-wa.org

Home - Hearing Loss Association of America - Washington State

Hearing Loss Association of America – Washington State. Opening the world of communication. Skip to primary content. Skip to secondary content. Hearing Loss Association of America. Let’s Loop Seattle. Public Access / ADA Information. Speech Reading / Lip Reading. Hearing Loss Association of Washington. Take Action * *. SB 5179 – Hearing Aids Needed for Medicaid Adults. The Olympian published the Letters to Editor by Cynthia Stewart. HLAA-WA Letter to Washington Senators for OTC Hearing Aids. Another HLAA...